Pulmatrix PULM
NASDAQ PULM
$1.50 0.00 (-0.33%)
As of: Aug 21, 2026 · 3:45 PM EDT

Pulmatrix (PULM) Non-Current Deffered Revenue (2015 - 2023)

Pulmatrix (PULM) posted Non-Current Deffered Revenue of $3.7 million for Q4 2023, down 7.7% sequentially from $4.0 million in Q3 2023, and down 22.71% YoY from $4.8 million in Q4 2022.

Pulmatrix (PULM) Non-Current Deffered Revenue (2015 - 2023) Analysis & Trends

Pulmatrix has reported Non-Current Deffered Revenue for 9 years, with the latest figure at $3.7 million in Q4 2023.

  • Quarterly Non-Current Deffered Revenue fell 22.71% year-over-year to $3.7 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $3.7 million (down 22.71% YoY) and the FY2023 annual result came in at $3.7 million, down 22.71% from the prior year.
  • Non-Current Deffered Revenue declined to $3.7 million in Q4 2023 per PULM's latest filing, from $4.0 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $8.0 million in Q3 2020 and troughed at $3.7 million in Q4 2023.
  • A 5-year average of $5.6 million and a median of $5.4 million in 2021 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2019 and 2021: Non-Current Deffered Revenue surged 9558.21% in 2019, then sank 32.14% in 2021.
  • Over 5 years, Non-Current Deffered Revenue stood at $7.9 million in 2019, then decreased by 21.72% to $6.2 million in 2020, then fell by 1.61% to $6.1 million in 2021, then declined by 20.55% to $4.8 million in 2022, then dropped by 22.71% to $3.7 million in 2023.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $3.7 million, $4.0 million, and $4.3 million for Q4 2023, Q3 2023, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 147.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Pulmatrix 5.46 Mn 5.46 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 3.73 Mn
Sep 30, 2023 4.04 Mn
Jun 30, 2023 4.35 Mn
Mar 31, 2023 4.32 Mn
Dec 31, 2022 4.82 Mn
Sep 30, 2022 5.08 Mn
Jun 30, 2022 5.36 Mn
Mar 31, 2022 5.74 Mn
Dec 31, 2021 6.07 Mn
Sep 30, 2021 5.42 Mn
Jun 30, 2021 5.42 Mn
Mar 31, 2021 5.81 Mn
Dec 31, 2020 6.17 Mn
Sep 30, 2020 7.99 Mn
Jun 30, 2020 5.37 Mn
Mar 31, 2020 6.53 Mn
Dec 31, 2019 7.88 Mn
Sep 30, 2019 6.47 Mn
Jun 30, 2019 6.20 Mn
Sep 30, 2018 67,000.00